National Peripheral Artery Disease Awareness Month

United States

About

National Peripheral Artery Disease Awareness Month, observed throughout September, brings attention to peripheral artery disease (PAD), a common circulatory condition in which narrowed arteries reduce blood flow—often to the legs and feet. The observance encourages people to learn about PAD, recognize possible warning signs such as leg pain during walking, numbness, coldness, or slow-healing sores, and understand why early medical attention matters.

Throughout the month, communities and health organizations promote conversations about heart and blood-vessel health, regular checkups, and steps that can support circulation, including staying active, avoiding tobacco, and managing conditions such as diabetes, high blood pressure, and high cholesterol. National Peripheral Artery Disease Awareness Month is an opportunity to share reliable information, support those affected by PAD, and inspire proactive care for healthier lives.

History

National Peripheral Artery Disease Awareness Month is observed throughout September to increase public understanding of peripheral artery disease (PAD), a circulatory condition in which narrowed or blocked arteries—most often in the legs—reduce blood flow. Although PAD has long been recognized as a consequence of atherosclerosis, it has historically received less public attention than heart attack and stroke. The observance developed in response to this awareness gap and to the need for earlier recognition of a disease that can signal widespread cardiovascular problems.

Its history is closely connected with the growth of vascular medicine and patient advocacy. Medical organizations, vascular specialists, public-health groups, and people living with PAD have worked to explain the condition’s major risk factors, including smoking, diabetes, high blood pressure, high cholesterol, and advancing age. These efforts have emphasized that symptoms may be subtle: leg pain or cramping during walking, numbness, weakness, coldness, or slow-healing wounds can all warrant medical evaluation. In some people, PAD produces few noticeable symptoms, making screening conversations and preventive care especially important.

Over time, the September observance has expanded beyond simply describing blocked arteries. Educational campaigns now stress PAD’s connection to atherosclerosis elsewhere in the body and its association with increased risks of heart attack, stroke, disability, and limb-threatening complications. Awareness initiatives commonly encourage people to discuss symptoms and risk factors with health professionals, control conditions such as diabetes and hypertension, stop smoking, remain physically active when medically appropriate, and follow recommended treatment. The broader approach reflects advances in diagnosis and treatment, including the use of the ankle-brachial index, supervised exercise, medication, and—in selected cases—revascularization procedures.

Culturally, National Peripheral Artery Disease Awareness Month helps make an often-overlooked illness more visible and supports more informed conversations between patients, families, and clinicians. It also highlights health disparities, since PAD can be especially serious among older adults and people affected by diabetes, tobacco exposure, or limited access to preventive care. By dedicating the whole of September to education and prevention, the observance connects individual stories with a wider public-health message: recognizing symptoms early and managing cardiovascular risk can help preserve mobility, prevent complications, and improve quality of life.

Timeline

1948
French vascular surgeon Jean Kunlin performed the first femoropopliteal bypass using a reversed segment of saphenous vein, a landmark operation for restoring blood flow around femoral artery occlusion.
1963
Thomas J. Fogarty reported the balloon-tipped embolectomy catheter, which enabled less invasive removal of arterial emboli and became an important tool in peripheral vascular surgery.
1964
Charles T. Dotter and Melvin P. Judkins performed and reported the first percutaneous transluminal angioplasty, dilating a stenosed superficial femoral artery in a patient facing leg amputation.
1996
The CAPRIE trial was published in The Lancet, comparing clopidogrel with aspirin in patients with recent stroke, myocardial infarction, or symptomatic peripheral arterial disease; its results helped shape antiplatelet treatment for PAD.

Upcoming dates

Sources

Same day

Related